IN2008MU02299A - - Google Patents
Download PDFInfo
- Publication number
- IN2008MU02299A IN2008MU02299A IN2299MU2008A IN2008MU02299A IN 2008MU02299 A IN2008MU02299 A IN 2008MU02299A IN 2299MU2008 A IN2299MU2008 A IN 2299MU2008A IN 2008MU02299 A IN2008MU02299 A IN 2008MU02299A
- Authority
- IN
- India
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2299MU2008 IN2008MU02299A (en) | 2008-10-24 | 2008-10-24 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2299MU2008 IN2008MU02299A (en) | 2008-10-24 | 2008-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2008MU02299A true IN2008MU02299A (en) | 2010-08-06 |
Family
ID=82701996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2299MU2008 IN2008MU02299A (en) | 2008-10-24 | 2008-10-24 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2008MU02299A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017020125A1 (en) * | 2015-07-31 | 2017-02-09 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
WO2022155352A1 (en) * | 2021-01-13 | 2022-07-21 | Dyve Biosciences, Inc. | Transdermal penetrant formulations for administration of medicaments |
WO2022155341A1 (en) * | 2021-01-13 | 2022-07-21 | Dyve Biosciences, Inc. | Transdermal formulations for phosphodiesterase-5 inhibitors |
-
2008
- 2008-10-24 IN IN2299MU2008 patent/IN2008MU02299A/en unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017020125A1 (en) * | 2015-07-31 | 2017-02-09 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
US10898537B2 (en) | 2015-07-31 | 2021-01-26 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
WO2022155352A1 (en) * | 2021-01-13 | 2022-07-21 | Dyve Biosciences, Inc. | Transdermal penetrant formulations for administration of medicaments |
WO2022155341A1 (en) * | 2021-01-13 | 2022-07-21 | Dyve Biosciences, Inc. | Transdermal formulations for phosphodiesterase-5 inhibitors |
CN115379837A (en) * | 2021-01-13 | 2022-11-22 | 黛芙生物科学公司 | Transdermal formulations for drug administration |